Owkin Funding: $334M Raised, Series B (2022)

Owkin funding overview

Owkin is based in Paris, France. Owkin has raised $334M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2022. The round record for Owkin runs through 2022; nothing later has been disclosed. Investors on record include Sanofi, Bristol-Myers Squibb, Google Ventures (GV), Bpifrance, Fidelity Management & Research, Cathay Innovation and 4 others. 10 distinct backers are named across the disclosed rounds.

Owkin at a glance

Total raised: $334M
Latest round: Series B
Latest round date: June 2022
Headquarters: Paris, France
Notable investors: Sanofi, Bristol-Myers Squibb, Google Ventures (GV), Bpifrance, Fidelity Management & Research, Cathay Innovation, Otium Capital, Eight Roads Ventures

Frequently asked about Owkin funding

How much has Owkin raised?: Owkin has raised $334M in total disclosed funding across the rounds on record.
Who has invested in Owkin?: Sanofi, Bristol-Myers Squibb, Google Ventures (GV), Bpifrance, Fidelity Management & Research, Cathay Innovation are named among the investors backing Owkin.
What was the latest Owkin funding round?: The most recent disclosed round is a Series B, announced in June 2022.
Where is Owkin based?: Owkin is based in Paris, France.
When did Owkin last raise?: The last disclosed Owkin round closed in June 2022 at Series B.

Owkin totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Paris below to benchmark round size and investor mix.

Owkin Funding: $334M Raised, Series B (2022)

Owkin funding overview

Owkin at a glance

Frequently asked about Owkin funding

Companies related to Owkin (36)

Browse related funding lists (7)